BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

York Pharma PLC 

P O Box 48

Hitchin  Hertfordshire  SG5 3ZH  United Kingdom
Phone: +44-0)-870-066-4453 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
ULURU Inc. Discussions to Acquire York Pharma PLC (YRK) Terminated 6/25/2009 6:50:31 AM
ULURU Inc. Signs Offer Letter to Acquire York Pharma PLC (YRK) 4/7/2009 7:38:21 AM
York Pharma PLC (YRK): Market Update 2/3/2009 11:56:01 AM
York Pharma PLC (YRK) Receives A Translation Award Of £100,014 From The Wellcome Trust For The Development Of A Specialist Wound Care Product 12/16/2008 12:49:01 PM
York Pharma PLC (YRK) Acquires Two Marketed Specialist Wound Care Products from Celltran Limited and £510,000 Institutional Placing 10/28/2008 8:13:31 AM
York Pharma PLC (YRK) Announces The Acquisition Of Leading Dermatological & Wound Care Brands; Company has Raised $51.2 Million to Finance the Product Acquisition and Support Future Operations 10/3/2008 1:35:34 PM
York Pharma PLC (YRK) Release: Acquisition of Leading Dermatological & Wound Care Brands, $48 Million (£24.2 Million) Financing and £3.9 Million Institutional Placing 7/8/2008 4:19:03 PM
York Pharma PLC (YRK) Release: New Abasol™ Formulation for Onychomycosis can Effectively and Rapidly Penetrate the Nail Barrier 10/31/2007 4:33:29 PM
York Pharma PLC (YRK) Release: Pre-IND Conference Requested to Enable International Phase IIb Study for Sabarep™ 10/23/2007 2:29:41 PM
York Pharma PLC (YRK) Acquires Derms Development for 17.5 Million stg 10/9/2007 11:29:09 AM
12